TXG 10x Genomics Inc Class A

10x Genomics Becomes First One Medical Customer to Deploy Cohort-Based COVID-19 Employee Testing 

10x Genomics Becomes First One Medical Customer to Deploy Cohort-Based COVID-19 Employee Testing 

Pioneering Effort for Safe Workplace Reentry

SAN FRANCISCO and PLEASANTON, Calif., May 19, 2020 (GLOBE NEWSWIRE) -- Today, (Nasdaq: TXG) and (Nasdaq: ONEM) announced the two organizations are partnering to pioneer a path toward the safe return to work by deploying a comprehensive approach to COVID-19 testing, digital employee symptom screening, and seamless access to remote and in-person care. 10x Genomics is the first of One Medical’s more than 7,000 employer customers to begin executing a multi-pronged, cohort-based return to the workplace strategy. 10x Genomics added One Medical as a new healthcare benefit for its employees and began offering voluntary SARS-CoV-2 PCR tests to monitor for possible infection.  As a part of the testing program, 10x Genomics has also teamed up with the (TGen), an affiliate of City of Hope, a non-profit medical institute working on COVID-19, for clinical testing of nasal swabs.

Deemed an essential business, 10x Genomics has more than 50 academic labs, research institutes and pharmaceutical companies around the world using its products to make discoveries to accelerate the development of therapeutics, diagnostics and vaccines for battling COVID-19. These include the Vanderbilt Vaccine Center, where researchers are fast-tracking the development of antibody-based prophylaxis to protect people, particularly first responders and essential workers, who are at greatest risk of exposure to COVID-19; Merck, which is working on identifying new viral targets for potential COVID-19 therapeutics and vaccines; and multiple labs around the world conducting research into cellular mechanisms and immune responses to infection, and other aspects of COVID-19.

To continue delivering its essential products and services, 10x Genomics partnered with One Medical to deploy its workplace reentry program, Healthy Together, to quickly operationalize an open-air testing site for COVID-19 PCR nasal swab collection tests at its Pleasanton headquarters. The nasal swab tests are sent to TGen’s COVID-19 clinical laboratory for analysis. 10x Genomics already has over 150 employees from its R&D, manufacturing and IT groups enlisted in the program that are being regularly tested in cohorts. 10x Genomics plans to expand the program to cover more than 65 percent of its employee base.

“The pandemic has forced us to be innovative and to forge new paths to navigate the complexities of the new workplace. We believe cohort-based testing is a powerful way, along with other recommended practices, to ensure the safety of employees,” said Ben Hindson, 10x Genomics Co-founder, President and Chief Scientific Officer.  “In One Medical, we have a partner that shared our dedication to employee health, applied a methodical science-based approach to workplace reentry and moved rapidly to operationalize the effort.” 

“10x Genomics is paving the way and modeling the behavior many employers should look to deploy in their organizations. By understanding the importance of broad COVID-19 testing among its employee base, they are showing that cohort-based reentry programs can work well when individuals are armed with necessary information about their COVID-19 status and are willing to use that information to support their employer’s risk mitigation efforts,” said Raj Behal, MD, MPH, One Medical Chief Quality Officer. 

About 10x Genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including 97 of the top 100 global research institutions and 19 of the top 20 global pharmaceutical companies, and have been cited in over 860 research papers on discoveries ranging from oncology to immunology and neuroscience. The company's patent portfolio comprises more than 740 issued patents and patent applications.

About One Medical 

One Medical is a membership-based and technology-powered primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click. Our vision is to delight millions of members with better health and better care while reducing costs. Our mission is to transform health care for all through our human-centered, technology-powered model.

Headquartered in San Francisco, 1Life Healthcare, Inc. is the administrative and managerial services company for the affiliated One Medical physician-owned professional corporations that deliver medical services in-office and virtually. 1Life and the One Medical entities do business under the “One Medical” brand.

Media Contact:

Kristina Skinner, One Medical

Director of External Communications



(650) 743-5187

10x Genomics

EN
19/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on 10x Genomics Inc Class A

Adrian Loh Tzum Yung ... (+4)
  • Adrian Loh Tzum Yung
  • Heidi Mo Jinghui
  • Llelleythan Tan Tan
  • Singapore Research Team

Singapore Daily: Monday, April 15, 2024

KEY HIGHLIGHTS Strategy The Impact Of Escalating Middle East Tensions A fluid situation with oil prices the key worry. Small/Mid Cap Highlights BRC Asia (BRC SP/BUY/S$1.94/Target: S$2.42) 1QFY24: Strong results as construction demand recovers. TRADERS’ CORNER Aztech Global (AZTECH SP): Trading BUY Isdn Holdings (ISDN SP): Trading BUY

FR FIRST INDUSTRIAL REALTY TRUST INC.
G13 GENTING SINGAPORE
FCT FRASERS CENTREPOINT TRUST
CC3 STARHUB LTD
S63 SINGAPORE TECHNOLOGIES ENGINEERING LTD
D05 DBS GROUP HOLDINGS LTD
C09 CITY DEVELOPMENTS LIMITED
S68 SINGAPORE EXCHANGE LTD.
V03 VENTURE CORPORATION LIMITED
U96 SEMBCORP INDUSTRIES LTD.
F34 WILMAR INTERNATIONAL LIMITED
BN2 VALUETRONICS HOLDINGS
B8O YANGZIJIANG SHIPBUILDING (HOLDINGS) LTD.
1820 ABDULMOHSEN AL HOKAIR GROUP FOR TOURISM AND DEVELOPMENT CO CJSC
AJBU KEPPEL DC REIT
C52 COMFORTDELGRO CORPORATION LIMITED
C6L SINGAPORE AIRLINES LTD.
Z74 SINGAPORE TELECOMMUNICATIONS LIMITED
O39 OVERSEA-CHINESE BANKING CORPORATION LIMITED
Y92 THAI BEVERAGE PUBLIC CO. LTD.
BN4 KEPPEL CORPORATION LIMITED
SE SEA ADS
SATS SP SATS LTD.
CDREIT CDL HOSPITALITY TRUSTS
SUN SUNTECH SA
KREIT KEPPEL REIT
MLT MAPLETREE LOGISTICS TRUST
FEHT FAR EAST HOSPITALITY TRUST
NETLINK NETLINK NBN TRUST
SIE SIA ENGINEERING CO LTD
BAL BUMITAMA AGRI LTD
PREIT PARKWAYLIFE REAL ESTATE
SPOST SINGAPORE POST LTD
MINT MAPLETREE INDUSTRIAL TRUST
RFMD RAFFLES MEDICAL GROUP LTD
SASSR SASSEUR REAL ESTATE INVESTMENT TRUST
MUST MANULIFE US REAL ESTATE INV
BRC BRC ASIA LTD
TXG 10X GENOMICS INC CLASS A
FEH FOOD EMPIRE HOLDINGS LTD
UHU UNITED HAMPSHIRE US REIT
FRKN FRENCKEN GROUP LTD
LREIT SP LENDLEASE GLOBAL COMMERCIAL REIT
FLT FRASERS LOGISTICS & COMMERCIAL TRUST
KORE KEPPEL PACIFIC OAK US REIT
DCREIT DIGITAL CORE REIT
ADSE ADS TEC ENERGY PLC
CLI CAPITALAND INVESTMENT LTD
MPACT MAPLETREE PAN ASIA COMMERCIAL TRUST
BCOW 1895 BANCORP OF WISCONSIN INC
CLAS CAPITALAND ASCOTT TRUST
CLAR CAPITALAND ASCENDAS REIT
PRIME PRIME ROAD POWER PUBLIC CO LTD
STM SEATRIUM LTD
Z29 029 GROUP SE
ACG ACG ACQUISITION COMPANY LIMITED
Jo Yee Ng ... (+3)
  • Jo Yee Ng
  • Shirley Wang Xueyi
  • Stella Guo Yuting

China Consumer: Focus on four key theses for the sector.

In this report, we have summarised what we read from consumer companies’ 2023 results, the 2024 outlook and recent updates. We think companies: a) with overseas expansion or turnaround prospects, b) that have upside potential of improving operating efficiency, c) that will benefit from near-term catalysts (eg event-driven), and d) have increasing dividend payout will outperform. Anta, CR Beer, CTGDF, Galaxy, Haidilao, Haier, Midea and Shenzhou are our most preferred stocks. Maintain OVERWEIGHT.

Johnny Yum ... (+2)
  • Johnny Yum
  • Stevanus Juanda

Indonesia Daily - Wednesday, April 3, 2024

Alpha Picks: Outperformance In Mar 24 and 1Q24 : Our picks are ACES, BBTN, CMRY, SIDO, EXCL, MAPI, JSMR, CTRA, and AKRA. Mitra Adiperkasa (MAPI IJ/BUY/Rp1,895/Target: Rp2,100) : 4Q23: Core NPAT below expectations due to high tax rate. TRADERS’ CORNER Aneka Tambang (ANTM IJ): Technical BUY Harum Energy (HRUM IJ): Technical BUY

Keith Wee Teck Keong
  • Keith Wee Teck Keong

Banking - Risk To Reward Remains Well Balanced

Loans growth edged upwards to 5.8% in Feb 24 (Jan 24: 5.7%) on the recovery in both the HH and business segments and household loans. We anticipate a 5.5-6.0% system loans growth for 2024, implying a 1.18x loans to GDP growth multiple which is in line with its 10-year mean. We find the sector’s risk to reward well-balanced (mean valuation) in the absence of strong catalysts. The sector’s 2024 earnings growth is expected to lag the broader equity market. Maintain MARKET WEIGHT with CIMB being our...

Hybridan Small Cap Feast - 18 Mar 24

18th March 2024 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment object...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch